HFS
RARE icon

Hughes Financial Services’s Ultragenyx Pharmaceutical RARE Stock Holding History

Hughes Financial Services’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$33 Hold
1
– – ﹤0.01% 1688
2026
Q1 		$21 Buy
+1
New +$23 ﹤0.01% 1613
2025
Q3 		– Sell
-14
Closed -$393 – 1090
2025
Q2 		$393 Buy
+14
New +$505 ﹤0.01% 1012

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Hughes Financial Services's RARE Position: Q2 2026 in Review

Hughes Financial Services held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 1 share worth $33. The position accounts for ﹤0.01% of the portfolio, ranked #1688.

Hughes Financial Services first reported a position in RARE in Q2 2025 and has held it in 3 quarters since. The position peaked at $393 in Q2 2025. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Hughes Financial Services held 1 share of Ultragenyx Pharmaceutical worth $33 as of Q2 2026.
  • Hughes Financial Services left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
  • Ultragenyx Pharmaceutical made up ﹤0.01% of Hughes Financial Services's portfolio in Q2 2026, its #1688 holding.
  • Hughes Financial Services first reported a position in Ultragenyx Pharmaceutical in Q2 2025 and has held it in 3 quarters since.
  • Hughes Financial Services's Ultragenyx Pharmaceutical position peaked at $393 in Q2 2025.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Hughes Financial Services's 13F filing for Q2 2026, filed 20 Jul 2026.